Cancer

Dolph Lundgren says he considered assisted suicide after receiving a two- to three-year cancer prognosis, before a second opinion led to treatment that left him with no evidence of disease.

The boy, whose liver cancer had spread to his lungs, suffered no dangerous side effects and remained cancer-free a year later. The post Three-Year-Old Boy’s Metastatic Cancer Disappears After Two Shots of Experimental Cell Therapy appeared first on SingularityHub.

TUESDAY, Sept. 22, 2026 — Mindfulness meditation or tai chi can help cancer survivors feel better, a new study says.Patients had less pain, fatigue and sleep problems after participating in mindfulness sessions or ancient Chinese mind-body...

New research from the Garvan Institute of Medical Research has revealed for the first time that two closely related bowel diseases, currently treated in the same way, are fundamentally different.

Positive EMA opinions for Abiraterone Mylan, Enhertu, Keytruda, Padcev, Pepaxti, and Tecvayli would broaden use of several therapies and move some into earlier treatment settings.

A large UK study finds that people who consume very hot beverages have a higher risk for ESCC, but the absolute risk remains low.

For a young person, completing cancer treatment can mark a long-awaited return to everyday life - education, work, relationships and plans for a family.

Donald Trump has defended restricting CNN, MS NOW and Politico from the White House as the organisations sue, arguing that the move unlawfully targets critical reporting.

Simply switching off a protein that helps breast cancer cells to grow? That is not enough for researchers at the University of Duisburg-Essen.

The main difference between Lilly's newly approved imlunestrant/abemaciclib combination and AstraZeneca's camizestrant/anti-CDK 4/6 option is when the endocrine therapy is switched.

In patients with Cushing syndrome due to adrenocortical carcinoma, more severe cortisol excess at diagnosis is associated with an increased risk for tumor recurrence or progression.

New leads for rare cancers, children, and inequalities will hold ministers to more than 100 plan commitments.

Despite routine guidelines, the number of women skipping cervical cancer screening is climbing — leaving clinicians to close a dangerous gap in preventive care.

A new generation of cellular therapy is producing durable responses in lymphoma and multiple myeloma, while clinicians assess its expanding role and distinct long-term toxicities.

Kim Kardashian's hospitalization sparks concern after a diagnosis linked to the same type of cancer that killed her father.

In two large US prospective cohorts, consuming more than one sugar-sweetened beverage a day was associated with higher gastric cancer incidence compared with consuming less than one serving a month. Artificially sweetened beverages were not associated with gastric cancer incidence, and the authors called for further studies to confirm the findings and clarify possible biological mechanisms.

A large UK cohort study found that higher BMI at age 20 was associated with lower postmenopausal breast cancer risk, while higher BMI in later adulthood was linked to increased risk. Lower VAS percentage mammographic density appeared to explain part of the early-adulthood association, while fibroglandular volume showed a different relationship with life-course adiposity.

A study initiated by a University of Arizona Cancer Center physician-scientist Dr. Dan Theodorescu revealed that the loss of the Y chromosome in men's body tissue could pave the way for cancer to develop in that tissue.

A new biomaterial developed by researchers from The University of Western Australia is providing fresh insights into the

A study initiated by Dr. Dan Theodorescu, a physician-scientist at the University of Arizona Cancer Center, revealed that the loss of the Y chromosome in men's body tissue could pave the way for cancer to develop. According to research recently published in JCI Insights, the loss of the chromosome, which is common in men as they age, creates a preneoplastic field effect, a hidden zone of genetic vulnerability in normal tissue that provides fertile ground for cancer to develop.

County Durham and Darlington NHS Trust admits 20 women had unnecessary mastectomies as reviews, police inquiries and calls for a public inquiry gather pace.

Researchers from the National University of Singapore (NUS) have demonstrated an innovative approach for targeted breast cancer therapy using pulsed electromagnetic fields (PEMFs).

Women with a higher Body Mass Index in early adulthood may have a lower risk of developing breast cancer after the menopause because of lasting changes in the structure of their breast tissue, according to researchers at The University of Manchester and Manchester University NHS Foundation Trust.

Only replacing sitting with physical activity seems to help.

A structured nurse-led support program combining in-person and virtual sessions reduces death anxiety among women with breast cancer undergoing hormonal therapy, a study reports.

A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.

A yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.

Big Picture Bio Ltd., has been founded to identify, design and optimize promising cancer combination therapies, using a generative world model to understand how tumors, immune cells and surrounding tissue interact across disease sites and patient subgroups.

Patients in England with an incurable breast cancer can now access a life-extending drug on the NHS, two years after it was deemed too expensive by a health body.

Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.

One of the biggest challenges in cancer immunotherapy may not be that immune cells are too weak, but that some tumors give them too little to see.

A rare inherited mutation in the Epidermal Growth Factor Receptor (EGFR) gene is associated with a 25-fold increased risk of lung cancer, according to a study by investigators at Dana-Farber Cancer Institute and 23andMe Research Institute.

A genetic mutation that raises lung cancer risk was much more common among those born in Southeastern states than elsewhere in the U.S.

The gene is found predominantly in Southern Appalachia and may be one of the most powerful cancer-risk mutations ever found.

The gene is found predominantly in Southern Appalachia and may be one of the most powerful cancer-risk mutations ever found.

CVS Health's Aetna health insurance unit will cut back next year on the preapprovals it requires for treatment ⁠for cancer patients to only one medical prior authorization...

Sexual wellbeing can often be overlooked during a woman's recovery from breast cancer with many continuing to experience significant sexual and intimacy challenges long after treatment ends.

Researchers develop and validate a deep learning model using longitudinal 3D tomosynthesis examinations to predict individualized 5-year risk for breast cancer.

Nature is the foremost international weekly scientific journal in the world and is the flagship journal for Nature Portfolio. It publishes the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature publishes landmark papers, award winning news, leading comment and expert opinion on important, topical scientific news and events that enable readers to share the latest discoveries in science and evolve the discussion amongst the global scientific community.

THURSDAY, Sept. 17, 2026 — An experimental blood test might be able to detect pancreatic cancer at its earliest stages, potentially saving countless lives, a new study says.The test, called PANXEON, correctly identified early-stage pancreatic...

NICE has approved Enhertu for eligible women in England after a new drug deal and higher cost-effectiveness threshold made the treatment affordable for NHS funding.

Scientists discovered a hidden “immune organ” inside the skull that acts as a rapid first responder against brain cancer in mice. Strengthening this local immune defense improved tumor rejection and survival, raising the possibility of new treatments that target the skull directly.

Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3, an antioxidant defense that tumors use to survive intense oxidative stress. In an early clinical trial, it controlled disease progression in 67% of patients and produced encouraging survival results, raising hopes that the strategy could eventually be used against other cancers.

A study finds that physicians often underestimated urinary and bowel symptoms but overestimated sexual symptoms compared with patient reports in men receiving prostate RT.

The cancer journey for many patients doesn’t end after treatment. Many live with long-term side effects that affect their ability to sleep and cause pain, impacting daily life.

A square peg doesn't fit a round hole. But what if the peg could change the shape of the hole?

Cytological tests are a common method of screening cancer cells from stained cell samples. Using a microscope, pathologists examine cells collected from bodily fluids, looking for tell-tale signs of malignancy like enlarged nuclei or abnormal cell shapes.

A new study published in Nature has established the foundational landscape of tumor evolution in bladder cancer and differences in the cancer subtypes, which could point toward better diagnosis and treatment of the disease.

WEDNESDAY, Sept. 16, 2026 — Taya Hailstone has been in remission from childhood Hodgkin lymphoma for five years. But the cancer’s lasting damage to her organs and nerves can make basic tasks, like loading a dishwasher, hard.Still, Montana’s health...

WEDNESDAY, Sept. 16, 2026 — Exercise is already recommended to help people with cancer manage fatigue and improve quality of life. Now, there is evidence the benefits may go further.A new study finds structured exercise may help people with cancer...

Pancreatic cancer is typically caught in its latest stages, when it is hardest to treat

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with immunotherapy, according to a new study published in Nature Medicine.

Today, the American Association for Cancer Research (AACR) released the 16th edition of its annual Cancer Progress Report.

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the country, led the development of a new, investigational blood test that could detect pancreatic cancer at its earliest stages, when the disease is more treatable and potentially curable.

Short, veteran-led clips could stem fear, anxiety associated with screening

Digital twins allow doctors to simulate treatment to see what will work best — and the tech has made real strides in cardiology. Oncology remains the bigger challenge.

Oncologists know that intensive treatment rarely helps patients in their final days but recognizing when someone is entering that stage is difficult, especially in metastatic breast cancer, where an increasing number of effective treatments has helped prolong life and given patients and oncologists more treatment options.

In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.

A new 3D-structure of a cancer-linked protein bound to its cellular partner reveals details of how the protein binds to chromosomes and could offer insights for future disease treatments.

A ChemSec report warns that leading PFAS manufacturers are planning production expansions driven by AI datacentres, semiconductors and batteries, despite growing regulatory efforts to limit exposure.

Cardiovascular disease has surpassed cancer as the leading cause of death among Hispanic adults in the U.S., driven by rising rates of obesity, diabetes, high blood pressure and other risk factors that often begin earlier in life for Hispanic people.

He developed a program that became a model for hospitals around the world, making it easier for poor Black patients to navigate an onerous bureaucratic system.

He developed a program that became a model for hospitals around the world, making it easier for poor Black patients to navigate an onerous bureaucratic system.

TUESDAY, Sept 15, 2026 — Women’s risk of having a harmless tumor caught and treated as a result of breast cancer screening is much lower than once thought, a new evidence review has concluded.Overdiagnosis — the detection of breast cancers that...

When women take part in breast cancer screening, they are informed that screening may detect cancers that would never have caused symptoms or problems during their lifetime. This is known as overdiagnosis.

In contrast to prior research showing PPI may mask signs of gastric cancer and delay diagnosis, new research shows diagnosis was in fact earlier and mortality, lower.

Mobile low-dose computed tomography (LDCT) screening can reach high-risk and socially vulnerable populations in resource-limited settings, according to initial results from the Third Brazilian Early Lung Cancer Trial (BRELT3) presented at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC).

Final results from the landmark PAPILLON trial, which changed the standard of care for a difficult-to-treat rare form of lung cancer, confirm that amivantamab, when added to chemotherapy, provides durable clinical benefit and the longest median overall survival reported to date for people with the disease.

New results from the global Phase I/II ARROS-1 trial showed clinically meaningful activity with zidesamtinib in patients with advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who had not previously received a tyrosine kinase inhibitor (TKI).

The phase III TAISHAN-302 trial found that tambotatug pelitecan (Tam-Peli, YL201), a novel anti-B7-H3 antibody-drug conjugate, significantly improved overall survival, progression-free survival and objective response rate compared with topotecan in patients with relapsed small-cell lung cancer (SCLC).

Results from the international phase III SWOG S1827 MAVERICK trial show that brain MRI surveillance alone improved cognitive failure-free survival compared with MRI surveillance plus prophylactic cranial irradiation (PCI) in patients with small-cell lung cancer (SCLC).

Results from the randomized Phase III ARTEMIS-008 trial show that risvutatug rezetecan (Ris-Rez), a B7-H3-directed antibody-drug conjugate, significantly improved overall survival compared with topotecan in patients with relapsed small-cell lung cancer (SCLC) whose disease progressed on or after platinum-based chemotherapy.

In pooled prospective data from 977,282 UK adults, preferring tea or coffee “very hot” was associated with more than threefold higher risk of esophageal squamous cell carcinoma compared with preferring drinks “warm,” while drink temperature showed no material association with adenocarcinoma risk. Consuming six or more hot drinks daily was independently associated with higher squamous cell carcinoma risk, and modeling estimated that about 440 UK cases each year could be prevented by switching from “very hot” to “hot” drinks if the association is causal.

Japanese actress Yuri Nakamura has died aged 44 from rectal cancer. Her agency said she continued acting during treatment before her condition worsened in August.

A new 3D structure of a cancer-linked protein bound to its cellular partner reveals details of how the protein binds to chromosomes and could offer insights for future disease treatments. The protein—BRD4—plays a critical role in how cells read, copy and repair DNA and helps determine how different kinds of cells are made; it has been linked to many types of cancer and is considered a promising target for future therapies. The study, led by scientists at Penn State and published in the journal Molecular Cell, found that BRD4 can attach to DNA-packaging structures in cells even without a molecular signal long believed to be necessary for the interaction.

MONDAY, Sept. 14, 2026 — Many people afflicted by rare appendix cancers may not need post-surgical chemotherapy, new research shows.In most cases, such treatment won't prevent tumor recurrence or extend patient survival, according to a study of...

Cancer rates are rising in adults under 55, and new research suggests accelerated biological aging may be one piece of the puzzle. Scientists found that people from more recent generations tended to have bodies that appeared biologically older than those of earlier generations at the same chronological age. Greater biological age acceleration was linked to a higher risk of early onset cancers, with specific patterns seen for lung, gastrointestinal, uterine and colorectal cancers.

Arizona has sued L'Oreal SA and its U.S. subsidiary, alleging the cosmetics company hid evidence that its hair relaxer products could cause cancer ⁠in women, as it faces...

AstraZeneca's breast cancer pill failed to meet the main goal of improving progression-free survival in a ⁠late-stage trial, the company said on Friday, a week after the...

Country and blues singer Nat Myers has withdrawn from the remaining Age of the Ram tour dates with Charley Crockett, citing medical appointments and the need to focus on cancer treatment.

An AI algorithm accurately evaluates pathologic response after neoadjuvant chemoimmunotherapy in patients with NSCLC, showing moderate concordance with expert pathologist consensus across cohorts.

After 5 years of follow-up, pembrolizumab plus chemotherapy continues to demonstrate sustained survival advantages in patients with persistent, recurrent, or metastatic cervical cancer.

Most men may be missing an important dietary clue about prostate cancer. A new survey found that only 20% knew research has linked dairy consumption with increased prostate cancer risk, while 66% said they would consider avoiding dairy after learning about the connection. Studies have also associated plant-based diets with substantially lower risks of prostate cancer, progression, and recurrence.

Researchers found that blocking IL1RAP could disrupt a powerful inflammatory network that helps pancreatic cancer survive treatment. In preclinical experiments, the approach reduced tumor-protecting cells and fibrosis while boosting the activity of cancer-fighting T cells. That could make chemotherapy and immunotherapy more effective.

Researchers trained AI on how expert pathologists look for signs of cancer in patient samples, improving the algorithm's effectiveness.

The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to conduct a clinical trial testing genetically engineered immune cells in adults with advanced colorectal cancer and pediatric patients with solid cancers who have exhausted standard treatment options.

A research team at Huntsman Cancer Institute at the University of Utah (the U) has found that obesity prevents a biological process that kills cancerous cells, revealing a possible reason why obesity is a risk factor for breast cancer.

Adelaide University researchers have developed a new way of using mRNA technology to reprogram tumor-supporting immune cells and strengthen the body's anti-cancer immune response.

FRIDAY, Sept. 11, 2026 — Twenty-five years after the World Trade Center attacks, cancer has become the defining health problem among survivors who breathed the toxic dust.The number who are getting help paying for cancer treatment has roughly...

Researchers used DNA sequencing to map mutations in normal tissue from cancer patients undergoing different types of treatment. They found significant differences in the genetic mutations in healthy tissue, depending on whether the patients received radiotherapy, chemotherapy, or chemoradiation. The post Cancer Treatment Genetic Effects in Healthy Cells May Reveal Clues to Side Effects and Resistance appeared first on GEN - Genetic Engineering and Biotechnology News.

Iron is an essential micronutrient, but excess iron can damage cells and increase cancer risk. While many cells die from iron-induced oxidative stress, a subset survives and may become cancerous.

People who drank at least one sugar-sweetened beverage a day had roughly 2.45 times the risk of gastric cancer compared with those who rarely consumed them, according to a decades-long study of more than 112,000 U.S. adults. Artificially sweetened drinks showed no similar association, though researchers stress that the findings do not prove sugary beverages cause cancer.

UCLA researchers developed ready-made cancer-fighting T cells from cord blood stem cells that can attack solid tumors through two separate detection systems. In mice, a single dose controlled cancer and extended survival while avoiding a dangerous complication associated with donor-derived T-cell therapies.

Cancer treatments, including chemotherapy and radiotherapy, give a growth advantage to cells with particular genetic changes in healthy tissue, new research finds.

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Medicare spending on prostate cancer care rose sharply from 2012 to 2021, driven largely by increased spending on systemic therapies.

In a prospective analysis of 1,098 people with colorectal cancer, researchers found no significant association between total or caffeinated coffee intake and all-cause or colorectal cancer-specific mortality in the cohort overall. Decaffeinated coffee was associated with lower all-cause mortality, while the highest quartile of caffeine intake was associated with lower all-cause and colorectal cancer-specific mortality, although the observational study cannot establish causation.

A study found people who had their drinks "very hot" had around a three times higher risk of the cancer than "warm" tea or coffee drinkers.